Corcept Therapeutics

CORT · NASDAQ

$116.45+$4.35 (+3.88%)TodayMarket closed ·
Prev close $112.10

Who owns CORT

Largest institutional holders, from their latest 13F filings

The 10 largest institutions hold 48.8% of CORT’s shares.

  • BlackRock Institutional Trust Company, N.A.10.5%
  • Ingalls & Snyder LLC (Asset Management)7.3%
  • Baker (George Leonard Jr.)5.1%
  • Renaissance Technologies LLC4.9%
  • Next 6 largest institutions20.9%
  • All other shareholders51.2%
Top institutional holders of CORT
HolderShares% of shares
BlackRock Institutional Trust Company, N.A.11.40M10.54%
Ingalls & Snyder LLC (Asset Management)7.93M7.34%
Baker (George Leonard Jr.)5.55M5.13%
Renaissance Technologies LLC5.26M4.87%
Vanguard Portfolio Management, LLC5.04M4.67%
Vanguard Capital Management, LLC4.17M3.86%
Parallel Advisors, LLC3.96M3.67%
State Street Investment Management (US)3.28M3.03%
Fidelity Management & Research Company LLC3.22M2.98%
Belanoff (Joseph K)2.92M2.70%

Largest mutual fund holders

Top mutual fund holders of CORT
HolderShares% of shares
iShares Core S&P Small-Cap ETF5.82M5.39%
Vanguard Total Stock Market Index Fund2.90M2.69%
Vanguard Small-Cap Index Fund2.10M1.94%
Fidelity Contrafund1.46M1.35%
Vanguard Small-Cap Growth Index Fund1.21M1.12%

Insider trades

Form 4 filings by officers, directors and large holders

Over the last 6 months, insiders sold $83.33M (89 trades) of CORT on the open market, with no buys.

Latest CORT insider transactions
InsiderTypeSharesValue
WILSON JAMES NSale300$34.89K
WILSON JAMES NSale3.05K$351.48K
WILSON JAMES NSale6.65K$761.72K
Vieira Roberto WandenkolkOption exercise8.33K—
Vieira Roberto WandenkolkSale5.15K$600.06K
Vieira Roberto WandenkolkSale2.09K$241.41K
Vieira Roberto WandenkolkSale1.10K$125.97K
Vieira Roberto WandenkolkOption exercise8.33K$180.24K
Lyon Joseph DouglasOption exercise5.83K—
Lyon Joseph DouglasOption exercise3.36K—

Short interest

Settled Sep 30, 2026

Shares short
8.54M
Days to cover
3.57
% of shares outstanding
7.90%
Average daily volume
2.39M
Change since last report
−8.7%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.